Interventions for steroid-resistant nephrotic syndrome: A systematic review

Pediatric Nephrology

Volumn 18, Issue 9, 2003, Pages 906-912

  Habashy, Doaa ^a   Hodson, Elisabeth M ^a   Craig, Jonathan C ^b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Angiotensin converting enzyme inhibitors; Corticosteroids; Immunosuppressive agents; Meta analysis; Steroid resistant nephrotic syndrome

Indexed keywords

ALKYLATING AGENT; ALPHA TOCOPHEROL; AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FISH OIL; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PLACEBO; PREDNISONE; STEROID;

BONE MARROW SUPPRESSION; CHILD CARE; CLINICAL STUDY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; GINGIVA HYPERPLASIA; HEMORRHAGIC CYSTITIS; HUMAN; HYPERTENSION; INFECTION; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA AND VOMITING; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CHILD; CYCLOSPORINE; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEPHROTIC SYNDROME; PREDNISONE; RANDOMIZED CONTROLLED TRIALS;

EID: 0141634350     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1207-0     Document Type: Review

References (32)

1. Schlesinger ER, Sultz HA, Mosher WE, Feldman JG (1968) The nephrotic syndrome: its incidence and implications for the community. Am J Dis Child 116:623-632
2. McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 16:1040-1044
3. Hodson EM, Willis NS, Craig JC (2000) Incidence of nephrotic syndrome in children in Australia. Seventh Asian Congress of Pediatric Nephrology, 4-6 November, Singapore
4. International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159-165
5. International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561-564
6. International Study of Kidney Disease in Children (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial proliferation. Kidney Int 20:765-771
7. Cattran DC, Rao P (1998) Long-term outcome in children and adults with classic focal and segmental glomerulosclerosis. Am J Kidney Dis 32:72-79
8. Niaudet P and the French Society of Pediatric Nephrology (1994) Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J Pediatr 125:981-986
9. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84-88
10. Dickersin K, Scherer R, Lefebvre C (1994) Identifying relevant studies for systematic reviews. BMJ 309:1286-1291
11. Lefebvre C, McDonald S (1996) Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Proceedings of the 4th International Cochrane Colloquium, Adelaide, Australia, 20-24 October
12. Willis N, Craig J, Mitchell R, Higgins G, Duty S, Cochrane Renal Group (2002) In: The Cochrane Library, Issue 4. Update Software, Oxford
13. Review Manager (RevMan) 4.0 for Windows (2000) The Cochrane Collaboration, Oxford
14. Adeniyi A, Hendrickse RG, Soothill JF (1979) A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria. Arch Dis Child 54:204-207
15. Garin EH, Orak JK, Hiott KL, Sutherland SE (1988) Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study. Am J Dis Child 142:985-988
16. Bagga A, Mudigoudar BD, Vasudev V, Hari P (2000) Low (LD) versus high dose (HD) enalapril therapy in steroid resistant nephrotic syndrome (SRNS). Seventh Asian Congress of Pediatric Nephrology, 4-6 November, Singapore
17. Chongviriyaphan N, Tapaneya-Olarn C, Suthutvoravut U, Karnchanachumpol S, Chantraruksa V (1999) Effects of tuna fish oil on hyperlipidemia and proteinuria in childhood nephrotic syndrome. J Med Assoc Thai 82 [Suppl] 1:S122-S128
18. Lieberman KV, Tejani A (1996) A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 7:56-63
19. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Della Casa-Alberighi O (1993) A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43:1377-1384
20. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590-593
21. Anonymous (1974) Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Report of the International Study of Kidney Disease in Children. Lancet II:423-427
22. Elhence R, Gulati S, Kher V, Gupta A, Sharma RK (1994) Intravenous pulse cyclophosphamide - a new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol 8:1-3
23. Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo P, Hallman N, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A Report for the International Study of Kidney Disease in Children. Lancet 1:959-961
24. Tune BM, Lieberman E, Mendoza SA (1996) Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr Nephrol 10:772-778
25. Hari P, Bagga A, Jindal N, Srivastava RN (2001) Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol 16:901-905
26. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408-412
27. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609-613
28. Hollis S, Cambell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319:670-674
29. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano, R, Lama G, Zacchello G, Confalonierei R, Altieri P, Bettinelli A, Maschio G, Cinotti GA, Fuiano G, Schena FP, Castellani A, Casa-Alberighi O della (1993) Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 8:1326-1332
30. Burgess E (1999) Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int 55 [Suppl 70]:S25-S32
31. Niaudet P (1992) Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Pediatr Nephrol 6:1-3
32. Latta K, Schnakenburg C von, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271-282